|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 | |||
| A61K 38/19 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3559034 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17829176.1 |
| Europos patento paraiškos padavimo data | 2017-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/083222 |
| Data | 2017-12-18 |
| (87) | Numeris | WO 2018/114748 |
| Data | 2018-06-28 |
| (30) | Numeris | Data | Šalis |
| 16205493 | 2016-12-20 | EP |
| (72) |
BACAC, Marina, CH
FERRARA KOLLER, Claudia, CH
KLEIN, Christian, CH
PERRO, Mario, CH
SAM, Johannes, CH
UMAŃA, Pablo, CH
XU, Wei, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND 4-1BB (CD137) AGONISTS |
| COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND 4-1BB (CD137) AGONISTS |